In addition, IGF2BP1 is an oncofetal RNA-binding protein that is strongly upregulated in PRAD and LUAD, where it is known to stabilize oncogenic transcripts, including those related to immune checkpoint signaling. Here, IGF2BP1 is linked to prostate adenocarcinoma.